Compounds and agents with a dominant or highly significant dopaminergic modulating mechanism of action
Pramipexole is a dopamine agonist (D2/D3/D4) that has displayed indications for promoting neurogenesis and treatment of bipolar and unipolar depression. Libidogenic capacity has also been demonstrated. Supplied as 60mg Pramipexole Dihydrochloride Monohydrate 99% in a solution of bascteriostatic water at 15mg/ml 4ml (within a 1 dram amber borosilicate...
Amisulpride 99% Amisulpride functions primarily as a D2 and D3 receptor antagonist, as well as at 5HT7, with low nanomolar affinity. Low dose administration demonstrates selective blockade of the pre-synaptic DA autoreceptors. These affinities have demonstrated a high degree of rapid-onset efficacy as an antidepressant. Research Indications:...
Amfonelic Acid 99% CAS 15180-02-6 Amfonelic Acid is a potent, long-lasting, and very highly selective dopamine reuptake inhibitor (DRI). Long-acting DRI agents have research indications for enhancing focus, concentration, and motivation, as well as treating conditions such as ADHD.
DARI-OX is a scientifically engineered proprietary Optimized Dopamine Reuptake Inhibitor Xtract with high selectivity for the dopamine transporter (DAT) and a ratio of selectivity to noradrenaline (NET) and serotonin transporters (SERT) very similar to classical DARI reference standards. Research Indications: Vigilance/Focus, ADHD, Parkinson's
Haloperidol marketed under the trade name Haldol among others, is a typical antipsychotic medication. Haloperidol is used in the treatment of schizophrenia, tics in Tourette syndrome, mania in bipolar disorder, nausea and vomiting, delirium, agitation, acute psychosis, and hallucinations in alcohol withdrawal.
9-Methyl-9B-Carboline is a dopaminergic enhancer that up-regulates, differentiates and protects dopaminergic neurons, dendrities and synapses, especially in the substantia nigra of the midbrain and in the hippocampus, as well as enhances dopamine synthesis. Research Indications: Dopaminergic Research, Addiction Research, Neuroprotection Research